ESH Video

NEW DATES! EXTENDED DEADLINE FOR ABSTRACTS: 7th Translational Research Conference on MDS

May 14, 2020


January 28-30, 2021

Mandelieu-La Napoule, France
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres


Due to the COVID-19 outbreak, the conference had been postponed
until January 2021 and the deadline for abstracts extended
until November 17, 2020.

We look forward to seeing you all again
and in the meantime everyone at ESH wishes you all the best. Stay safe!



The 7th ESH Conference on Myelodysplastic Syndromes (MDS) is designed to provide time and multiple opportunities for critical discussion and informal scientific interaction with internationally recognized experts in the field.
Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates. In separate sessions results from both basic and clinical research will be presented.

Posters and Brief Oral Communications:
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

The meeting will be of interest to:
- Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
- Junior scientists and clinicians (MD, PhD)
- PhD candidates and clinical residents still in-training

- Learn how to optimally diagnose MDS, by morphological analysis and cytogenetics but also through the use of new tools, mainly for molecular analysis.
- Improve ability to analyze prognostic factors, including new factors (revised IPSS, molecular analysis).
- Review current treatment of MDS in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
- Acquire improved knowledge of emerging treatments based on targeted therapies and well conducted clinical trials.

Click here for more information and for registration!


With the support of*:

Diamond Conference Partner


Ruby Conference Partners

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors